Position in TNYA
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$11,939
New position
Shares Held
17,253
first reported quarter
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 103 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Arkadios Wealth Advisors holds $12,704,540 across 13 Biotechnology names. TNYA ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,435 | $3,426,657 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
11,960 | $2,261,037 | |
| 3 | TYRA |
Tyra Biosciences, Inc.
|
47,567 | $1,821,816 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,684 | $1,645,052 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
19,622 | $1,268,169 | |
| 6 | MRNA |
Moderna, Inc.
|
17,857 | $907,135 | |
| 7 | EXEL |
Exelixis, Inc.
|
11,098 | $475,992 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
9,416 | $447,918 |
All Filings in TNYA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,939 | 17,253 | Shares | Sole | 2026-05-18 | |
| No filing history on record for this holder in this stock. | ||||||